J Neurol Surg B Skull Base 2018; 79(03): 309-313
DOI: 10.1055/s-0037-1607320
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Long-Term Facial Nerve Outcomes after Microsurgical Resection of Vestibular Schwannomas in Patients with Preoperative Facial Nerve Palsy

Michael A. Mooney
1   Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
,
Benjamin Hendricks
1   Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
,
Christina E. Sarris
1   Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
,
Robert F. Spetzler
1   Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
,
Kaith K. Almefty
1   Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
,
Randall W. Porter
1   Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
› Author Affiliations
Further Information

Publication History

02 May 2017

10 September 2017

Publication Date:
03 November 2017 (online)

Abstract

Objectives This study aimed at evaluating facial nerve outcomes in vestibular schwannoma patients presenting with preoperative facial nerve palsy.

Design A retrospective review.

Setting Single-institution cohort.

Participants Overall, 368 consecutive patients underwent vestibular schwannoma resection. Patients with prior microsurgery or radiosurgery were excluded.

Main Outcome Measures Incidence, House–Brackmann grade.

Results Of 368 patients, 9 had confirmed preoperative facial nerve dysfunction not caused by prior treatment, for an estimated incidence of 2.4%. Seven of these nine patients had Koos grade 4 tumors. Mean tumor diameter was 3.0 cm (range: 2.1–4.4 cm), and seven of nine tumors were subtotally resected. All nine patients were followed up clinically for ≥ 6 months. Of the six patients with a preoperative House–Brackmann grade of II, two improved to grade I, three were stable, and one patient worsened to grade III. Of the three patients with grade III or worse, all remained stable at last follow-up.

Conclusions Preoperative facial nerve palsy is rare in patients with vestibular schwannoma; it tends to occur in patients with relatively large lesions. Detailed long-term outcomes of facial nerve function after microsurgical resection for these patients have not been reported previously. We followed nine patients and found that eight (89%) of the nine patients had either stable or improved facial nerve outcomes after treatment. Management strategies varied for these patients, including rates of subtotal versus gross-total resection and the use of stereotactic radiosurgery in patients with residual tumor. These results can be used to help counsel patients preoperatively on expected outcomes of facial nerve function after treatment.

 
  • References

  • 1 Rinaldi V, Casale M, Bressi F. , et al. Facial nerve outcome after vestibular schwannoma surgery: our experience. J Neurol Surg B Skull Base 2012; 73 (01) 21-27
  • 2 Schmitt WR, Daube JR, Carlson ML. , et al. Use of supramaximal stimulation to predict facial nerve outcomes following vestibular schwannoma microsurgery: results from a decade of experience. J Neurosurg 2013; 118 (01) 206-212
  • 3 Falcioni M, Fois P, Taibah A, Sanna M. Facial nerve function after vestibular schwannoma surgery. J Neurosurg 2011; 115 (04) 820-826
  • 4 Samii M, Gerganov V, Samii A. Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients. J Neurosurg 2006; 105 (04) 527-535
  • 5 Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. Neurosurgery 1997; 40 (01) 1-9 , discussion 9–10
  • 6 Neely JG, Neblett CR. Differential facial nerve function in tumors of the internal auditory meatus. Ann Otol Rhinol Laryngol 1983; 92 (1 Pt 1): 39-41
  • 7 Dunn IF, Bi WL, Erkmen K. , et al. Medial acoustic neuromas: clinical and surgical implications. J Neurosurg 2014; 120 (05) 1095-1104
  • 8 Kurokawa Y, Uede T, Hashi K. Factors influencing the long-term function of the facial nerve following removal of acoustic neurinomas [in Japanese]. No Shinkei Geka 1997; 25 (03) 225-230
  • 9 Inamasu J, Shiobara R, Kagami H, Sato S, Kawase T, Kanzaki J. Medial (intra-cisternal) acoustic neuromas. Acta Otolaryngol 2000; 120 (05) 623-626
  • 10 Anderson DE, Leonetti J, Wind JJ, Cribari D, Fahey K. Resection of large vestibular schwannomas: facial nerve preservation in the context of surgical approach and patient-assessed outcome. J Neurosurg 2005; 102 (04) 643-649
  • 11 Tos M, Youssef M, Thomsen J, Turgut S. Causes of facial nerve paresis after translabyrinthine surgery for acoustic neuroma. Ann Otol Rhinol Laryngol 1992; 101 (10) 821-826
  • 12 Bloch O, Sughrue ME, Kaur R. , et al. Factors associated with preservation of facial nerve function after surgical resection of vestibular schwannoma. J Neurooncol 2011; 102 (02) 281-286
  • 13 Darrouzet V, Martel J, Enée V, Bébéar JP, Guérin J. Vestibular schwannoma surgery outcomes: our multidisciplinary experience in 400 cases over 17 years. Laryngoscope 2004; 114 (04) 681-688
  • 14 Brackmann DE, Cullen RD, Fisher LM. Facial nerve function after translabyrinthine vestibular schwannoma surgery. Otolaryngol Head Neck Surg 2007; 136 (05) 773-777
  • 15 Gormley WB, Sekhar LN, Wright DC, Kamerer D, Schessel D. Acoustic neuromas: results of current surgical management. Neurosurgery 1997; 41 (01) 50-58 , discussion 58–60
  • 16 Sampath P, Holliday MJ, Brem H, Niparko JK, Long DM. Facial nerve injury in acoustic neuroma (vestibular schwannoma) surgery: etiology and prevention. J Neurosurg 1997; 87 (01) 60-66
  • 17 Esses BA, LaRouere MJ, Graham MD. Facial nerve outcome in acoustic tumor surgery. Am J Otol 1994; 15 (06) 810-812
  • 18 Fenton JE, Chin RY, Fagan PA, Sterkers O, Sterkers JM. Predictive factors of long-term facial nerve function after vestibular schwannoma surgery. Otol Neurotol 2002; 23 (03) 388-392
  • 19 Jacob A, Robinson Jr LL, Bortman JS, Yu L, Dodson EE, Welling DB. Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center. Laryngoscope 2007; 117 (12) 2087-2092
  • 20 Veronezi RJ, Fernandes YB, Borges G, Ramina R. Long-term facial nerve clinical evaluation following vestibular schwannoma surgery. Arq Neuropsiquiatr 2008; 66 (2A): 194-198
  • 21 Nonaka Y, Fukushima T, Watanabe K. , et al. Contemporary surgical management of vestibular schwannomas: analysis of complications and lessons learned over the past decade. Neurosurgery 2013; 72 (2, Suppl Operative): ons103-ons115 , discussion ons115
  • 22 Hardy DG, Macfarlane R, Baguley D, Moffat DA. Surgery for acoustic neurinoma. An analysis of 100 translabyrinthine operations. J Neurosurg 1989; 71 (06) 799-804
  • 23 Arriaga MA, Luxford WM, Atkins Jr JS, Kwartler JA. Predicting long-term facial nerve outcome after acoustic neuroma surgery. Otolaryngol Head Neck Surg 1993; 108 (03) 220-224
  • 24 Sterkers JM, Morrison GA, Sterkers O, El-Dine MM. Preservation of facial, cochlear, and other nerve functions in acoustic neuroma treatment. Otolaryngol Head Neck Surg 1994; 110 (02) 146-155
  • 25 Rudman KL, Rhee JS. Habilitation of facial nerve dysfunction after resection of a vestibular schwannoma. Otolaryngol Clin North Am 2012; 45 (02) 513-530 , xi
  • 26 Xiao FL, Gao PY, Sui BB. , et al. Time-course of changes in activation among facial nerve injury: a functional imaging study. Medicine (Baltimore) 2015; 94 (43) e1582
  • 27 Carlson ML, Van Abel KM, Schmitt WR, Driscoll CL, Neff BA, Link MJ. The anatomically intact but electrically unresponsive facial nerve in vestibular schwannoma surgery. Neurosurgery 2012; 71 (06) 1125-1130 , discussion 1130